Clinical efficacy of piracetam in cognitive impairment: a meta-analysis
T. Waegemans, C. R. Wilsher, A. Danniau, S. H. Ferris, A. Kurz, B. Winblad · 2002 · Dementia and Geriatric Cognitive Disorders 13:217–224
What does this source report?
Reported a favorable pooled clinical global impression of change. This differs from the memory-specific outcome in the 2024 analysis.
- Population and setting
- 19 double-blind placebo comparisons in older patients with cognitive impairment
- Evidence type
- Review
- Preparation
- See the original report; formulation details require verification.
- Source language
- English
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Several authors were affiliated with UCB; the search included the manufacturer’s document database.
- Older diagnostic definitions and outcome measures varied.
- A review is not independent replication of its underlying trials.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
University-hosted PDF: title page, abstract and study-selection methods checked; full risk-of-bias reassessment pending.
Recorded source-check date: 2026-09-30. This date does not imply a completed systematic review.
Cite and trace this record
Original source: T. Waegemans, C. R. Wilsher, A. Danniau, S. H. Ferris, A. Kurz, B. Winblad. Clinical efficacy of piracetam in cognitive impairment: a meta-analysis Dementia and Geriatric Cognitive Disorders 13:217–224 2002.
Molekul research summary: https://molekul.io/research/pir-meta-2002. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry